Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PepGNP SARSCoV2

Next Previous
X
Search
Drug Profile

PepGNP SARSCoV2

Alternative Names: CoronaTcP; naNo-COVID; PepGNP-COVID19; PepGNP-SARSCoV2; T-Cell Priming COVID-19 vaccine

Latest Information Update: 22 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Emergex Vaccines
  • Developer Gylden Pharma
  • Class COVID-19 vaccines; Peptide vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I COVID 2019 infections

Most Recent Events

  • 17 Oct 2024 Emergex Vaccines is now called Gylden Pharma
  • 03 Jan 2024 Philippines Food & Drug Administration approves IND application for phase I/II trial for PepGNP SARSCoV2 in COVID-2019 infections
  • 17 Nov 2023 Emergex Vaccines plans a phase II trial for COVID-2019 infections (Prevention) (Intradermal, Injection), in H1 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top